ID   PAHX_HUMAN              Reviewed;         338 AA.
AC   O14832; A8MTS8; B1ALH5;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   10-MAY-2017, entry version 172.
DE   RecName: Full=Phytanoyl-CoA dioxygenase, peroxisomal;
DE            EC=1.14.11.18;
DE   AltName: Full=Phytanic acid oxidase;
DE   AltName: Full=Phytanoyl-CoA alpha-hydroxylase;
DE            Short=PhyH;
DE   Flags: Precursor;
GN   Name=PHYH; Synonyms=PAHX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT RD TRP-275.
RX   PubMed=9326939; DOI=10.1038/ng1097-185;
RA   Mihalik S.J., Morrell J.C., Kim D., Sachsteder K.A., Watkins P.A.,
RA   Gould S.J.;
RT   "Identification of PAHX, a Refsum disease gene.";
RL   Nat. Genet. 17:185-189(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT RD HIS-269.
RX   PubMed=9326940; DOI=10.1038/ng1097-190;
RA   Jansen G.A., Ofman R., Ferdinandusse S., Ijlst L., Muijsers A.O.,
RA   Skjeldal O.H., Stokke O., Jakobs C., Besley G.T.N., Wraith J.E.,
RA   Wanders R.J.A.;
RT   "Refsum disease is caused by mutations in the phytanoyl-CoA
RT   hydroxylase gene.";
RL   Nat. Genet. 17:190-193(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Leukemia;
RX   PubMed=10051602; DOI=10.1073/pnas.96.5.2104;
RA   Chambraud B., Radanyi C., Camonis J.H., Rajkowski K., Schumacher M.,
RA   Baulieu E.-E.;
RT   "Immunophilins, Refsum disease, and lupus nephritis: the peroxisomal
RT   enzyme phytanoyl-CoA alpha-hydroxylase is a new FKBP-associated
RT   protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2104-2109(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS RD SER-29; SER-173;
RP   LYS-176; GLY-177; ALA-192 INS; ARG-193; GLN-197; PHE-199; SER-204;
RP   TYR-220; SER-257; HIS-269; GLN-275 AND TRP-275, AND VARIANT GLN-245.
RX   PubMed=10767344; DOI=10.1093/hmg/9.8.1195;
RA   Jansen G.A., Hogenhout E.M., Ferdinandusse S., Waterham H.R.,
RA   Ofman R., Jakobs C., Skjeldal O.H., Wanders R.J.A.;
RT   "Human phytanoyl-CoA hydroxylase: resolution of the gene structure and
RT   the molecular basis of Refsum's disease.";
RL   Hum. Mol. Genet. 9:1195-1200(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH PHYHIP.
RX   PubMed=10686344; DOI=10.1016/S0169-328X(99)00304-6;
RA   Lee Z.H., Kim H.-H., Ahn K.Y., Seo K.H., Kim J.K., Bae C.S., Kim K.K.;
RT   "Identification of a brain specific protein that associates with a
RT   Refsum disease gene product, phytanoyl-CoA alpha-hydroxylase.";
RL   Brain Res. Mol. Brain Res. 75:237-247(2000).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 31-338 IN COMPLEX WITH IRON
RP   AND ALPHA-KETOGLUTARATE, AND COFACTOR.
RX   PubMed=16186124; DOI=10.1074/jbc.M507528200;
RA   McDonough M.A., Kavanagh K.L., Butler D., Searls T., Oppermann U.,
RA   Schofield C.J.;
RT   "Structure of human phytanoyl-CoA 2-hydroxylase identifies molecular
RT   mechanisms of Refsum disease.";
RL   J. Biol. Chem. 280:41101-41110(2005).
RN   [11]
RP   REVIEW ON VARIANTS RD.
RX   PubMed=14974078; DOI=10.1002/humu.10315;
RA   Jansen G.A., Waterham H.R., Wanders R.J.A.;
RT   "Molecular basis of Refsum disease: sequence variations in phytanoyl-
RT   CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7).";
RL   Hum. Mutat. 23:209-218(2004).
RN   [12]
RP   VARIANT RD SER-204.
RX   PubMed=10709665;
RA   Jansen G.A., Ferdinandusse S., Hogenhout E.M., Verhoeven N.M.,
RA   Jakobs C., Wanders R.J.A.;
RT   "Phytanoyl-CoA hydroxylase deficiency. Enzymological and molecular
RT   basis of classical Refsum disease.";
RL   Adv. Exp. Med. Biol. 466:371-376(1999).
RN   [13]
RP   VARIANT GLN-245.
RX   PubMed=27535533; DOI=10.1038/nature19057;
RG   Exome Aggregation Consortium;
RA   Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E.,
RA   Fennell T., O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B.,
RA   Tukiainen T., Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K.,
RA   Zhao F., Zou J., Pierce-Hoffman E., Berghout J., Cooper D.N.,
RA   Deflaux N., DePristo M., Do R., Flannick J., Fromer M., Gauthier L.,
RA   Goldstein J., Gupta N., Howrigan D., Kiezun A., Kurki M.I.,
RA   Moonshine A.L., Natarajan P., Orozco L., Peloso G.M., Poplin R.,
RA   Rivas M.A., Ruano-Rubio V., Rose S.A., Ruderfer D.M., Shakir K.,
RA   Stenson P.D., Stevens C., Thomas B.P., Tiao G., Tusie-Luna M.T.,
RA   Weisburd B., Won H.H., Yu D., Altshuler D.M., Ardissino D.,
RA   Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C.,
RA   Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S.,
RA   Laakso M., McCarroll S., McCarthy M.I., McGovern D., McPherson R.,
RA   Neale B.M., Palotie A., Purcell S.M., Saleheen D., Scharf J.M.,
RA   Sklar P., Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C.,
RA   Wilson J.G., Daly M.J., MacArthur D.G.;
RT   "Analysis of protein-coding genetic variation in 60,706 humans.";
RL   Nature 536:285-291(2016).
CC   -!- FUNCTION: Converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA.
CC   -!- CATALYTIC ACTIVITY: Phytanoyl-CoA + 2-oxoglutarate + O(2) = 2-
CC       hydroxyphytanoyl-CoA + succinate + CO(2).
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000269|PubMed:16186124};
CC   -!- COFACTOR:
CC       Name=L-ascorbate; Xref=ChEBI:CHEBI:38290;
CC         Evidence={ECO:0000269|PubMed:16186124};
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC   -!- SUBUNIT: Interacts specifically with the immunophilin FKBP52 and
CC       PHYHIP. {ECO:0000269|PubMed:10686344,
CC       ECO:0000269|PubMed:16186124}.
CC   -!- INTERACTION:
CC       Q8IZU0:FAM9B; NbExp=6; IntAct=EBI-721853, EBI-10175124;
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O14832-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14832-2; Sequence=VSP_046289;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- TISSUE SPECIFICITY: Expressed in liver, kidney, and T-cells, but
CC       not in spleen, brain, heart, lung and skeletal muscle.
CC   -!- DISEASE: Refsum disease (RD) [MIM:266500]: A rare autosomal
CC       recessive peroxisomal disorder characterized by the accumulation
CC       of the branched-chain fatty acid, phytanic acid, in blood and
CC       tissues. Cardinal clinical features are retinitis pigmentosa,
CC       peripheral neuropathy, cerebellar ataxia, and elevated protein
CC       levels in the cerebrospinal fluid (CSF). Half of all patients
CC       exhibit generalized, mild to moderate ichthyosis resembling
CC       ichthyosis vulgaris. Less constant features are nerve deafness,
CC       anosmia, skeletal abnormalities, cataracts and cardiac impairment.
CC       {ECO:0000269|PubMed:10709665, ECO:0000269|PubMed:10767344,
CC       ECO:0000269|PubMed:14974078, ECO:0000269|PubMed:9326939,
CC       ECO:0000269|PubMed:9326940}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PhyH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF023462; AAB81834.1; -; mRNA.
DR   EMBL; AF112977; AAD20602.1; -; mRNA.
DR   EMBL; AF242386; AAF74123.1; -; Genomic_DNA.
DR   EMBL; AF242379; AAF74123.1; JOINED; Genomic_DNA.
DR   EMBL; AF242380; AAF74123.1; JOINED; Genomic_DNA.
DR   EMBL; AF242381; AAF74123.1; JOINED; Genomic_DNA.
DR   EMBL; AF242382; AAF74123.1; JOINED; Genomic_DNA.
DR   EMBL; AF242383; AAF74123.1; JOINED; Genomic_DNA.
DR   EMBL; AF242384; AAF74123.1; JOINED; Genomic_DNA.
DR   EMBL; AF242385; AAF74123.1; JOINED; Genomic_DNA.
DR   EMBL; AL138764; CAI12911.2; -; Genomic_DNA.
DR   EMBL; BC029512; AAH29512.1; -; mRNA.
DR   CCDS; CCDS41489.1; -. [O14832-2]
DR   CCDS; CCDS7097.1; -. [O14832-1]
DR   RefSeq; NP_001032626.1; NM_001037537.1. [O14832-2]
DR   RefSeq; NP_001310009.1; NM_001323080.1. [O14832-2]
DR   RefSeq; NP_006205.1; NM_006214.3. [O14832-1]
DR   UniGene; Hs.498732; -.
DR   PDB; 2A1X; X-ray; 2.50 A; A=31-338.
DR   PDBsum; 2A1X; -.
DR   DisProt; DP00327; -.
DR   ProteinModelPortal; O14832; -.
DR   SMR; O14832; -.
DR   BioGrid; 111282; 12.
DR   IntAct; O14832; 6.
DR   MINT; MINT-1411634; -.
DR   STRING; 9606.ENSP00000263038; -.
DR   DrugBank; DB00025; Antihemophilic Factor (Recombinant).
DR   DrugBank; DB00126; Vitamin C.
DR   SwissLipids; SLP:000001017; -.
DR   iPTMnet; O14832; -.
DR   PhosphoSitePlus; O14832; -.
DR   BioMuta; PHYH; -.
DR   EPD; O14832; -.
DR   MaxQB; O14832; -.
DR   PaxDb; O14832; -.
DR   PeptideAtlas; O14832; -.
DR   PRIDE; O14832; -.
DR   DNASU; 5264; -.
DR   Ensembl; ENST00000263038; ENSP00000263038; ENSG00000107537. [O14832-1]
DR   Ensembl; ENST00000396913; ENSP00000380121; ENSG00000107537. [O14832-2]
DR   GeneID; 5264; -.
DR   KEGG; hsa:5264; -.
DR   UCSC; uc001ime.4; human. [O14832-1]
DR   CTD; 5264; -.
DR   DisGeNET; 5264; -.
DR   GeneCards; PHYH; -.
DR   GeneReviews; PHYH; -.
DR   HGNC; HGNC:8940; PHYH.
DR   HPA; HPA007598; -.
DR   HPA; HPA011796; -.
DR   MalaCards; PHYH; -.
DR   MIM; 266500; phenotype.
DR   MIM; 602026; gene.
DR   neXtProt; NX_O14832; -.
DR   OpenTargets; ENSG00000107537; -.
DR   Orphanet; 773; Refsum disease.
DR   PharmGKB; PA33280; -.
DR   eggNOG; ENOG410IPBI; Eukaryota.
DR   eggNOG; COG5285; LUCA.
DR   GeneTree; ENSGT00390000001775; -.
DR   HOGENOM; HOG000007341; -.
DR   HOVERGEN; HBG000392; -.
DR   InParanoid; O14832; -.
DR   KO; K00477; -.
DR   OMA; WTAMERV; -.
DR   OrthoDB; EOG091G0F66; -.
DR   PhylomeDB; O14832; -.
DR   TreeFam; TF313667; -.
DR   BioCyc; MetaCyc:HS03003-MONOMER; -.
DR   BRENDA; 1.14.11.18; 2681.
DR   Reactome; R-HSA-389599; Alpha-oxidation of phytanate.
DR   UniPathway; UPA00199; -.
DR   EvolutionaryTrace; O14832; -.
DR   GenomeRNAi; 5264; -.
DR   PRO; PR:O14832; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107537; -.
DR   CleanEx; HS_PHYH; -.
DR   ExpressionAtlas; O14832; baseline and differential.
DR   Genevisible; O14832; HS.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0031406; F:carboxylic acid binding; IDA:CAFA.
DR   GO; GO:0048037; F:cofactor binding; IDA:UniProtKB.
DR   GO; GO:0008198; F:ferrous iron binding; IDA:CAFA.
DR   GO; GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0048244; F:phytanoyl-CoA dioxygenase activity; IDA:UniProtKB.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; IDA:CAFA.
DR   GO; GO:0001561; P:fatty acid alpha-oxidation; IDA:UniProtKB.
DR   GO; GO:0006720; P:isoprenoid metabolic process; IDA:UniProtKB.
DR   GO; GO:0097089; P:methyl-branched fatty acid metabolic process; IDA:UniProtKB.
DR   InterPro; IPR008775; Phytyl_CoA_dOase.
DR   Pfam; PF05721; PhyH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cataract; Complete proteome;
KW   Deafness; Dioxygenase; Disease mutation; Ichthyosis; Iron;
KW   Metal-binding; Oxidoreductase; Peroxisome;
KW   Peroxisome biogenesis disorder; Phosphoprotein; Polymorphism;
KW   Reference proteome; Retinitis pigmentosa; Transit peptide; Vitamin C.
FT   TRANSIT       1     30       Peroxisome. {ECO:0000250}.
FT   CHAIN        31    338       Phytanoyl-CoA dioxygenase, peroxisomal.
FT                                /FTId=PRO_0000024053.
FT   REGION      175    177       Alpha-ketoglutarate binding.
FT   METAL       175    175       Iron. {ECO:0000269|PubMed:16186124}.
FT   METAL       177    177       Iron. {ECO:0000269|PubMed:16186124}.
FT   METAL       264    264       Iron. {ECO:0000269|PubMed:16186124}.
FT   BINDING     120    120       Alpha-ketoglutarate.
FT                                {ECO:0000269|PubMed:16186124}.
FT   BINDING     157    157       Alpha-ketoglutarate.
FT                                {ECO:0000269|PubMed:16186124}.
FT   BINDING     193    193       Alpha-ketoglutarate.
FT                                {ECO:0000269|PubMed:16186124}.
FT   BINDING     266    266       Alpha-ketoglutarate.
FT                                {ECO:0000269|PubMed:16186124}.
FT   BINDING     275    275       Alpha-ketoglutarate.
FT                                {ECO:0000269|PubMed:16186124}.
FT   MOD_RES      59     59       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O35386}.
FT   MOD_RES     108    108       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O35386}.
FT   MOD_RES     231    231       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O35386}.
FT   MOD_RES     252    252       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O35386}.
FT   MOD_RES     317    317       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    100       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_046289.
FT   VARIANT      29     29       P -> S (in RD; unknown pathological
FT                                significance; dbSNP:rs28938169).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017482.
FT   VARIANT      83     83       N -> Y (in RD).
FT                                /FTId=VAR_018619.
FT   VARIANT     173    173       P -> S (in RD).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017483.
FT   VARIANT     175    175       H -> R (in RD).
FT                                /FTId=VAR_018631.
FT   VARIANT     176    176       Q -> K (in RD; dbSNP:rs28939672).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017484.
FT   VARIANT     177    177       D -> G (in RD; total loss of activity;
FT                                dbSNP:rs770262329).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017485.
FT   VARIANT     192    192       A -> AA (in RD).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_012980.
FT   VARIANT     193    193       W -> R (in RD).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017486.
FT   VARIANT     197    197       E -> Q (in RD).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017487.
FT   VARIANT     199    199       I -> F (in RD).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017488.
FT   VARIANT     204    204       G -> S (in RD; total loss of activity;
FT                                dbSNP:rs28939673).
FT                                {ECO:0000269|PubMed:10709665,
FT                                ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017489.
FT   VARIANT     215    215       G -> S (in dbSNP:rs7901902).
FT                                /FTId=VAR_050528.
FT   VARIANT     220    220       H -> Y (in RD; dbSNP:rs767216891).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017490.
FT   VARIANT     245    245       R -> Q (in dbSNP:rs62619919).
FT                                {ECO:0000269|PubMed:10767344,
FT                                ECO:0000269|PubMed:27535533}.
FT                                /FTId=VAR_017491.
FT   VARIANT     257    257       F -> S (in RD).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017492.
FT   VARIANT     269    269       N -> H (in RD; dbSNP:rs104894179).
FT                                {ECO:0000269|PubMed:10767344,
FT                                ECO:0000269|PubMed:9326940}.
FT                                /FTId=VAR_005525.
FT   VARIANT     275    275       R -> Q (in RD; total loss of activity;
FT                                dbSNP:rs28939674).
FT                                {ECO:0000269|PubMed:10767344}.
FT                                /FTId=VAR_017493.
FT   VARIANT     275    275       R -> W (in RD; total loss of activity;
FT                                dbSNP:rs28939671).
FT                                {ECO:0000269|PubMed:10767344,
FT                                ECO:0000269|PubMed:9326939}.
FT                                /FTId=VAR_005526.
FT   HELIX        57     64       {ECO:0000244|PDB:2A1X}.
FT   STRAND       65     69       {ECO:0000244|PDB:2A1X}.
FT   HELIX        75     89       {ECO:0000244|PDB:2A1X}.
FT   STRAND       99    101       {ECO:0000244|PDB:2A1X}.
FT   STRAND      104    106       {ECO:0000244|PDB:2A1X}.
FT   STRAND      115    117       {ECO:0000244|PDB:2A1X}.
FT   STRAND      120    122       {ECO:0000244|PDB:2A1X}.
FT   HELIX       128    135       {ECO:0000244|PDB:2A1X}.
FT   HELIX       137    147       {ECO:0000244|PDB:2A1X}.
FT   STRAND      149    161       {ECO:0000244|PDB:2A1X}.
FT   HELIX       177    180       {ECO:0000244|PDB:2A1X}.
FT   HELIX       186    188       {ECO:0000244|PDB:2A1X}.
FT   STRAND      189    197       {ECO:0000244|PDB:2A1X}.
FT   STRAND      206    208       {ECO:0000244|PDB:2A1X}.
FT   HELIX       212    214       {ECO:0000244|PDB:2A1X}.
FT   STRAND      246    248       {ECO:0000244|PDB:2A1X}.
FT   STRAND      255    258       {ECO:0000244|PDB:2A1X}.
FT   STRAND      264    266       {ECO:0000244|PDB:2A1X}.
FT   STRAND      271    273       {ECO:0000244|PDB:2A1X}.
FT   STRAND      275    284       {ECO:0000244|PDB:2A1X}.
FT   HELIX       296    301       {ECO:0000244|PDB:2A1X}.
FT   HELIX       320    327       {ECO:0000244|PDB:2A1X}.
FT   STRAND      329    333       {ECO:0000244|PDB:2A1X}.
SQ   SEQUENCE   338 AA;  38538 MW;  FBF9639E7C79A6B0 CRC64;
     MEQLRAAARL QIVLGHLGRP SAGAVVAHPT SGTISSASFH PQQFQYTLDN NVLTLEQRKF
     YEENGFLVIK NLVPDADIQR FRNEFEKICR KEVKPLGLTV MRDVTISKSE YAPSEKMITK
     VQDFQEDKEL FRYCTLPEIL KYVECFTGPN IMAMHTMLIN KPPDSGKKTS RHPLHQDLHY
     FPFRPSDLIV CAWTAMEHIS RNNGCLVVLP GTHKGSLKPH DYPKWEGGVN KMFHGIQDYE
     ENKARVHLVM EKGDTVFFHP LLIHGSGQNK TQGFRKAISC HFASADCHYI DVKGTSQENI
     EKEVVGIAHK FFGAENSVNL KDIWMFRARL VKGERTNL
//
